SYNAPSE | Research Management Partners

Enjoy your project.

Synapse is a firm specialized in the high quality management of complex research and development projects in the biomedical sector.

Synapse partners with national and international organisations, both public and private. Our company goes beyond classical project management and brings in added value capabilities in team management, vision management, strategic thinking and project intelligence. Synapse’s expertise extends to market knowledge, business planning and valorization of research results.

We are proudly celebrating our 10th anniversary.
Do not miss our anniversary highlights.

10th Anniversary Highlights

OUR PROJECTS

< >

PARADIGM
Current Projects
Patients Active in Research and Dialogues for an Improved Generation of Medicines The overall goal is to provide a framework that allows structured, meaningful, sustainable and...
eTRANSAFE
Current Projects
Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFE project aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the...
Drive
Current Projects
Development of Robust and Innovative Vaccine Effectiveness DRIVE aims at developing a governance model between public and private entities to enable a sustainable network of influenza...
RESCEU
Current Projects
RESCEU aims to investigate serious lung infections caused by respiratory syncytial virus (RSV) that particularly affect babies and older people, and those with weakened immune systems,...
TransQST
Current Projects
TransQST aims to develop novel computational approaches using the best available data from the public and private domains to improve the understanding of adverse drug reactions...
HARMONY
Current Projects
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONY aims at capturing, integrating, analysing and harmonising anonymous patient data from high-quality multidisciplinary sources to...
ROADMAP
Current Projects
Real world Outcomes across the AD spectrum for better care: Multi-modal data Access Platform ROADMAP aims to create the conditions for an open collaboration that yields...
AMYPAD
Current Projects
Amyloid imaging to prevent Alzheimer’s Disease The Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) project aims at studying the onset, dynamics, and clinical relevance of brain...
EPAD
Current Projects
European Prevention of Alzheimer’s Dementia The European Prevention of Alzheimer’s Dementia (EPAD) project aims to develop an infrastructure that efficiently enables the undertaking of adaptive, multi-arm...
ADVANCE
Current Projects
Accelerated development of vaccine benefit-risk collaboration in Europe The goal of the ADVANCE project is to develop a blueprint for a framework capable of rapidly delivering...
EMIF
Current Projects
European Medical Information Framework The EMIF project aims to be the trusted European hub for health care data intelligence, enabling new insights into diseases and treatments....

OUR PARTNERS

Check the full list of partners

LATEST NEWS

< >

02 Aug

EPAD and AMYPAD presented at the AAIC in Chicago, US
No Comments
The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic...
27 Jul

Meet our projects at the IMI Scientific Symposium in Brussels
No Comments
This year Innovative Medicines Initiative (IMI) is celebrating its10th anniversary, and this comes precisely in a year when Synapse is also celebrating its first decade of existence....
11 Jul

Synapse participates in the 3rd Real World Epidemiology Oxford Summer School
No Comments
Synapse has sponsored the third edition of the Real World Epidemiology Oxford Summer School. This course is aimed to explore the existing sources of real world...
06 Jul

SYNAPSE – Facts and Figures
No Comments
Ten years ago Innovative Medicines Initiative Joint Undertaking (IMI-JU) was created as a unique public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and...
06 Jul

ADVANCE BLUEPRINT IS OPEN FOR PUBLIC CONSULTATION
No Comments
Vaccines undergo rigorous testing prior to licensing for use, however it is important that the safety of vaccines is monitored on an ongoing basis. The ADVANCE...
27 Jun

SYNAPSE: from project management to value creation
No Comments
SYNAPSE is celebrating its 10th anniversary this year. The company has been steadily growing in size, expertise and in the complexity of the projects it is...
26 Jun

RESCEU 2nd General Assembly meets 18 months after the start of the project to discuss the progress made and present first results
No Comments
The Second General Assembly Meeting of the REspiratory Syncytial virus Consortium in EUrope (RESCEU) took place on 21-22 June at St Anne’s College in Oxford, bringing...
20 Jun

SYNAPSE is celebrating its 10th anniversary
No Comments
This year SYNAPSE is proud to celebrate its 10th anniversary with a highly positive balance: 25 projects in total, almost 20 people in our team and...
15 Jun

The ADVANCE Steering Committee met at Món St. Benet to define the last year project workplan and sustainability
No Comments
The ADVANCE project represents unique collaboration between key stakeholders in the sector, including European Centre for Disease Prevention and Control (ECDC), European Medicines Agency (EMA), national...
08 Jun

The 3rd eTRANSAFE Consortium Meeting held in Barcelona on the 4th and 5th of June
No Comments
Members of the 27 eTRANSAFE Consortium partners gathered for two days in Barcelona to review the progress of the project done in the past months. eTRANSAFE...
01 Jun

EPAD presented its next steps at the General Assembly Meeting held in Amsterdam
No Comments
The fourth EPAD General Assembly was held on May 23rd-35th in Amsterdam under the banner “How to Assure Sustainability?”. Almost 180 representatives from 37 partner institutions...